FRUQUINTINIB
Clinical trials for FRUQUINTINIB explained in plain language.
Never miss a new study
Get alerted when new FRUQUINTINIB trials appear
Sign up with your email to follow new studies for FRUQUINTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to hunt down hidden cancer after treatment
Disease control Recruiting nowThis study is testing whether a combination of two drugs, fruquintinib and tislelizumab, can help control colorectal cancer in patients who have finished their initial chemotherapy but still have tiny amounts of cancer left in their body, detected by a special blood test. The goa…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for advanced colon cancer patients who Can't tolerate chemo
Disease control Recruiting nowThis study is testing whether a combination of targeted cancer drugs, with or without immunotherapy, can control advanced colorectal cancer without using traditional chemotherapy. It's for patients with a specific genetic profile (RAS/BRAF wild-type) whose cancer has spread and c…
Matched conditions: FRUQUINTINIB
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for tough stomach cancers: testing a Triple-Threat treatment
Disease control Recruiting nowThis study is testing a new three-drug combination for people with advanced stomach or gastroesophageal cancer that has a specific marker called HER2-positive. The main goals are to find the safest and most effective dose of the new drug fruquintinib when added to two standard ca…
Matched conditions: FRUQUINTINIB
Phase: PHASE1, PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC